Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

AstraZeneca’s win in lung cancer; Sandoz inks a China deal

A combination of AstraZeneca's Tagrisso and Hutchmed's Orpathys extended survival for some lung cancer patients. Elsewhere, MapLight started seeking a partner for its autism drug.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Tuesday 18 August →